期刊文献+

二甲双胍联合双环醇治疗非乙醇性脂肪肝55例疗效观察 被引量:3

The efficacy of metformin combined with bicyclol in the treatment of nonalcoholic steatohepatitis
下载PDF
导出
摘要 目的:观察二甲双胍联合双环醇治疗非乙醇性脂肪肝的疗效。方法:将110例非乙醇性脂肪肝患者随机分为治疗组(n=55)及对照组(n=55)。治疗组在综合治疗基础上给予双环醇联合二甲双胍治疗;对照组综合治疗基础上,给予应用二甲双胍。全部病例均连续治疗12周,观察治疗前后临床症状、生化指标、肝脏B彩超的变化及药物不良反应。结果:治疗组患者临床表现、生化指标、肝脏彩超改变与对照组比较差异具有统计学意义(P<0.05)。结论:应用双环醇联合二甲双胍治疗脂肪肝患者疗效、安全性好,值得推广应用。 Objective To evaluate the efficacy of metformin combined with bicyclol treatment of nonalcoholic steatohepatitis.Method Total 110 cases of nonalcoholic steatohepatitis patients were randomly divided into the treatment group(n=55)and the control group(n=55).The treatment group based on the combined therapy combined with bicyclol to metformin;the control group based on the comprehensive treatment given application of metformin.All patients were treated for 12 consecutive weeks of treatment,clinical symptoms,biochemical parameters,liver changes and Color Doppler ultrasound B,adverse drug reactions were observed.Results The clinical manifestations of patients,biochemical indicators of liver ultrasonography changes compared with the control group,the difference was significant(P0.05).Conclusion Bicyclol combined with metformin treating patients with fatty liver with good efficacy and safety,should be widely applied.
出处 《吉林医学》 CAS 2011年第1期57-59,共3页 Jilin Medical Journal
关键词 双环醇 二甲双胍 非乙醇性脂肪肝 治疗 Bicyclol Metformin Nonalcoholic steatohepatitis Treatment
  • 相关文献

参考文献9

二级参考文献54

  • 1范建高.脂肪肝促发代谢紊乱和动脉硬化的机制[J].诊断学理论与实践,2007,6(2):108-110. 被引量:18
  • 2[1]Richter JE.Extraesophageal presentations manifestations of gastroesophageal reflux disease.Semin Gastrointest Gastroenterol Dis 1997;8:75-89
  • 3[2]Irwin RS,Richter JE.Gastroesophageal reflux and chronic cough.Am J Gastroenterol2000;95:S 9-S14
  • 4[3]Irwin RS,Curley FJ,French CL.Chronic cough:the The spectrum and frequency of causes,key components of the diagnostic evaluation,and outcome of specific therapy.Am Rev Respir Dis 1990;141:640-647
  • 5[4]Ours TM,Kavuru MS,Schilz RJ,Richter JE.A prospective evaluation of esophageal testing and a double-blind,randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough.Am J Gastroenterol1999;94:3131-3138
  • 6[5]Kiljander TO,Salomaa ERM,Hietanen EK,Terho EO.Chronic cough and gastro-oesophageal reflux:a double-blind placebocontrolled study with omeprazole.Eur Respir J 2000;16:633-638
  • 7[6]El-Serag HB,Lee P,Buchner A,Inadomi JM,Gavin M,McCarthy DM.Lansoprazole treatment of patients with chronic idiopathic laryngitis:a placebo-controlled trial.Am J Gastroenterol2001;96:979-983
  • 8[7]Armstrong D,Blum AL,Savary M.Reflux disease and Barrett's oesophagus.Endoscopy 1992;24:9-17
  • 9[8]Baldi F,Ferrarini F,Longanesi A.Ambulatory 24-hour esophageal pH monitoring in normal subjects:a multicentre study in Italy.Ital J Gastroenterol Baldi F,Ferrarini F,Longanesi A,Bersani G.Ambulatory 24-hour oesophageal pH monitoring in normal subjects:a multicentre study in Italy.G.I.S.M.A.D.GOR Study Group.Ital J Gastroenterol 1991;23:477-480
  • 10[9]Singh S,Richter JE,Bradley LA,Haile JM.The Ssymptom Indexindex:differential Differential usefulness in suspected acid-related complaints of heartburn and chest pain.Dig Dis Sci 1993;38:1402-1408

共引文献111

同被引文献39

  • 1杨创国,于乐成,陈金军,孙剑,郭亚兵,骆抗先,朱幼芙,侯金林.1686例慢性乙型肝炎中HBeAg阴性与阳性患者临床和病毒学特点比较分析[J].中华内科杂志,2005,44(9):648-651. 被引量:82
  • 2西原利治,路晓阳.药物诱发性NASH[J].日本医学介绍,2007,28(4):159-161. 被引量:5
  • 3Zhang J Y. New drugs derived from medicinal plants [J].Therapie, 2002,57(2):137-15.
  • 4LIU GT,ZHENG CZ, LI Y,et al. Clinical and Pharmacological study of Bicyelola potential anti-chronic viral hepatitis drug [J].Clin Med Sci J,1999,14 Suppl 51-53.
  • 5Yu YN, ChenH, LiY. Effect of bicyclol on cisplatin-Induced hepatotoxicity in the hepatoearcinoma 22 turnout-bearing mice [J]. Basic Clin Pharmacol Toxicol, 2009, 104(4): 300-305.
  • 6Zhao J, ChenH, LiY. Protective effect of bicyclol on acute aleohol-indueed liver injury in mice [J]. Eur J Pharmacol, 2008, 586 ( 1-3):322-33.
  • 7Pan SY, Dong H, Yu ZL, et al. Bicyclol, a synthetic dibenzocy- clooctadiene derivative, decreases hepatic lipids but increases serum triglyceride level in normal and hypercholesterolaemic mice [J]. J Pharm Pharmacol, 2007, 59(12): 1657-1662.
  • 8Bao XQ, Liu GT. Bicyclol: a novel antihepatitis drug with hepatic heat shock protein 27/70-inducing activity and cytoproteetive effects in mice [J]. Cell Stress Chaperones, 2008, 13(3): 347-355.
  • 9BaoXQ, Liu GT. Induction of overexpression of the 27-and 70-kDa heat shock proteins by bicyclol attenuates concanavalin a-induced liver injury through suppression of nuclear factor-KB in mice [J]. Mol Pharmaeol, 2009, 75(5): 1180-1188.
  • 10WON G DKH,CHENG AM, O'ROURKE K,et al. Effect of alpha interferon treatment in patients with hepatitis B e antigen positive chronic hepatitis B.A meta-analysis [J]. Ann Int Med,1993,119:312-323.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部